PSMA-GCK01

N/A

Report date: 2025/10/31 15:08:04

Base Information

Drug NamePSMA-GCK01

Drug Alias NamePSMA-GCK01-[99mTc] + PSMA-GCK01-[188Re][99mTc]-PSMA-GCK01 + [188Re]-PSMA-GCK01technetium-99m-PSMA-GCK01 + 188Rhenium-PSMA-GCK01

ClassificationBiologics > Protein drugs > Recombinant polypeptideRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) +[6]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesTelix Pharmaceuticals Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTelix Pharmaceuticals Ltd

Inactive CompaniesN/A

Active IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A